New Wearable Imaging to See How Breast Cancer Responds to Chemotherapy
3D wearable NIR spectral tomography for early prediction of breast cancer’s residual cancer burden after neoadjuvant chemotherapy
This project is developing a new wearable imaging device to help doctors see very early if breast cancer treatment is working for patients receiving chemotherapy before surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dartmouth College NIH-funded |
| Lab location | 1 site (Hanover, United States) |
| Project ID | NIH-11136328 on NIH RePORTER |
What this research studies
We are creating a special wearable device that uses near-infrared light to look inside breast tissue. This device can detect subtle changes in the breast tumor very early in treatment, even before the tumor size visibly shrinks. By seeing these changes quickly, doctors might be able to tell if your chemotherapy is effective. This non-invasive, low-cost imaging method could offer a new way to monitor treatment progress for breast cancer patients.
Who could benefit from this research
Good fit: This research is relevant for breast cancer patients who are undergoing chemotherapy before surgery.
Not a fit: Patients not receiving neoadjuvant chemotherapy for breast cancer would not directly benefit from this specific imaging approach.
Why it matters
Potential benefit: If successful, this new imaging method could help doctors adjust breast cancer treatment sooner, potentially leading to better long-term outcomes for patients.
How similar studies have performed: The researchers have previously developed a similar system and gathered clinical data from women, showing its potential to detect tumor response.
Where this research is happening
Hanover, United States
- Dartmouth College — Hanover, United States (Active)
Researchers
- Principal investigator: Jiang, Shudong — Dartmouth College
- Study coordinator: Jiang, Shudong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.